[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Martin et al., 1995 - Google Patents

Gadolinium (III) di-and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast …

Martin et al., 1995

Document ID
5295963947117628836
Author
Martin V
Ralston W
Hynes M
Keana J
Publication year
Publication venue
Bioconjugate chemistry

External Links

Snippet

Paramagnetic species enjoy wide use as contrast enhancing agents in biological and medical magnetic resonance imaging (MRI) applications owing to their ability to shorten the relaxation time of nearby water protons (1). Complexes of Gd (III) are particularly at-tractive …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers

Similar Documents

Publication Publication Date Title
JP3862299B2 (en) Polyamino acidated ligands and their metal complexes
RU2166501C2 (en) Cascade polymeric complexes, parent compounds and pharmaceutical composition
US5567411A (en) Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
Wiener et al. Dendrimer‐based metal chelates: a new class of magnetic resonance imaging contrast agents
US5330743A (en) Aminosaccharide contrast agents for magnetic resonance images
AU684453B2 (en) Cascade polymer bound chelating compounds, their chelates and conjugates, processes for their production, and pharmaceutical agents containing them
US5681544A (en) Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them
AU2002355333B2 (en) Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy
US6312664B1 (en) Biodegradable contrast media for MR imaging
Martin et al. Gadolinium (III) di-and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents
KR101469900B1 (en) DO3A-diaminobiphenyl compounds and Gadolinium complex comprising the same compounds as a ligand
EP0331616A2 (en) Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same
JPH05503072A (en) Hydroxy-aryl metal chelates for diagnostic NMR imaging
HUT76804A (en) Cascade-polymer complexes and methods of producing the same
DE60313585T2 (en) OLIGOMERS OF GADOLINIUM CHELATE, THEIR USE AS NMR CONTRASTIVE AND INTERMEDIATE COMPOUNDS
KR20040030826A (en) Macrocyclic Metal Complexes and Use Thereof for Production of Conjugates with Biomolecules
JP2004506631A (en) Perfluoroalkyl-containing complex having sugar residue, method for producing the same and use thereof
US6019959A (en) Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
Ndiaye et al. Comparison of MRI properties between multimeric DOTAGA and DO3A Gadolinium-Dendron conjugates
US6068831A (en) Pseudopolyrotaxanes
US6113880A (en) Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging
Hovland et al. Preparation and in vitro evaluation of GdDOTA-(BOM) 4; a novel angiographic MRI contrast agent
JP2001504843A (en) Macrocyclic metal complex carboxylic acid, its use and its production
CN118791488B (en) Compounds, chelates and their use in magnetic resonance imaging
CN118791488A (en) Compounds, chelates and their use in magnetic resonance imaging